Home › Funds › Coppell Advisory Solutions LLC › PCRX
Coppell Advisory Solutions LLC position in PCRX
PACIRA BIOSCIENCES INC COM · Health Care
Coppell Advisory Solutions LLC reported holding 16 shares of PCRX (PACIRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$5.6M, representing 0.46% of its reported portfolio and ranking #39 among its reported holdings. Coppell Advisory Solutions LLC has disclosed PCRX holdings in 2 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Coppell Advisory Solutions LLC's PCRX position evolved
Coppell Advisory Solutions LLC first disclosed a stake in PCRX in Q2 2024 at 58 shares (US$2K). The position peaked in Q2 2026 at 16 shares, worth US$5.6M. Across 2 filings, Coppell Advisory Solutions LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 16 shares valued at US$5.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 58 | $1.66K | New |
| Q2 2026 | 16 | $5.59M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCRX and 13F data
PCRX (PACIRA BIOSCIENCES INC COM) is a Health Care company. 24 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$88.7M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCRX
- Context Capital Management, LLC 88.81M sh · $88.73M · Q2 2026
- Doma Perpetual Capital Management LLC 2.78M sh · $70.47M · Q2 2026
- GAGNON SECURITIES LLC 608.62K sh · $15.44M · Q2 2026
More on Coppell Advisory Solutions LLC
FAQ
How long has Coppell Advisory Solutions LLC held PCRX?
Coppell Advisory Solutions LLC has disclosed PCRX holdings in 2 of the last 9 reported quarters, going back to Q2 2024.
What is Coppell Advisory Solutions LLC's current position in PCRX?
As of Q2 2026, Coppell Advisory Solutions LLC holds 16 shares of PCRX (PACIRA BIOSCIENCES INC COM), valued at $5.59M, representing 0.46% of its reported portfolio and ranking #39.
Has Coppell Advisory Solutions LLC been buying or selling PCRX?
In the latest 13F filing (Q2 2026), Coppell Advisory Solutions LLC newly opened its position in PCRX. The position peaked in Q2 2026 at 16 shares.
Which other funds hold PCRX?
Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.